David Cook's $1 Million Campaign For Brain Cancer Research To Culminate With Charity Concert On "#Giving Tuesday"

WASHINGTON, Nov. 7, 2014 /PRNewswire-USNewswire/ -- American Idol® winner and platinum selling recording artist, David Cook, will perform a charity concert at Jammin Java in Vienna, Virginia on December 2, 2014 (#Giving Tuesday) to benefit Accelerate Brain Cancer Cure (ABC²), a venture philanthropy organization.   #GivingTuesday is a global day of giving, held the day after Cyber Monday.

Since 2009, Cook and his fans have raised $930,000 for brain cancer research through the Race for Hope DC and various fundraisers.   This month, Cook's Crowdrise campaign aims to raise $70,000 to reach the $1 million mark.  The performance at Jammin Java will celebrate this milestone. 

Cook has been a champion for brain cancer research since losing his beloved brother Adam to the disease.  "It is one of my proudest life experiences to be involved in this fight," said Cook. "With help from my friends, I know we can reach $1 million and celebrate this amazing accomplishment together at the concert on December 2^nd." 

Cook is putting the finishing touches on a new album and the first single, "Wait for Me," will be available at iTunes and other digital retailers on November 17th.  He will perform this single at the Jammin Java benefit show.  

To contribute to Cook's Crowdrise campaign, click HERE.

To purchase tickets to Cook's charity concert, click HERE.

DAVID COOK
David Cook immediately launched to stardom following his Season 7 American Idol® title. A week after his victory, Cook broke several Billboard chart records when 14 of his songs debuted on the Hot Digital Songs chart and 11 of his songs debuted on the Hot 100.  Cook's recording career has spawned chart topping hits, a platinum album and multiple platinum singles.  Cook continues to tour throughout the world and his next studio album is set for release in 2015.

Accelerate Brain Cancer Cure (ABC²)
ABC² is a venture philanthropy 501(c) (3) nonprofit organization that drives cutting-edge research and treatments for brain tumors.   Through strategic partnerships with medical research centers, early-stage biotechnology companies and large multi-national pharmaceutical companies ABC² has awarded more than $20 million in brain tumor research funding to highly qualified investigators and physician-scientists from 42 institutions and companies.  Learn more at: www.abc2.org

Logo - http://photos.prnewswire.com/prnh/20141106/157195LOGO

SOURCE Accelerate Brain Cancer Cure

Related Links

http://www.abc2.org

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED